Active Ingredient (In Each Tablet)
Sennosides 8.6 mg
The following Structured Product Label (SPL) was submitted to the FDA by Advance Pharmaceutical Inc. for the product Senna (NDC 17714-122). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient (in each tablet), purpose, uses, do not use, ask a doctor before use if you have, stop use and ask a doctor if, if pregnant or breast-feeding,, keep out of reach of children., and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Sennosides 8.6 mg
Laxative
you have rectal bleeding or fail to have a bowel movement after use of a laxative. These may indicate a serious condition.
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away.
| a
ge | starting dosage
| maximum dosage |
| adults and children 12 years of age or older
| 2 tablets once a day
| 4 tablets twice a day
|
| children 6 to under 12 years
| 1 tablet once a day
| 2 tablets twice a day
|
| children 2 to under 6 years
| 1/2 tablet once a day
| 1 tablet twice a day
|
| children under 2 years
| ask a doctor
| ask a doctor
|
croscarmellose sodium, dibasic calcium phosphate dihydrate, hypromellose, , magnesium stearate, microcrystalline cellulose, mineral oil
call 631-981-4600, 8.30 am-4.30 pm ET, Monday - Friday
TAMPER EVIDENT: DO NOT USE IF IMPRINTED SAFETY SEAL UNDER CAP IS BROKEN OR MISSING
NDC: 17714-122-01
Senna 8.6mg
* Please review the disclaimer below.